To determine whether or not high plasma levels of glucose and insulin are involved in the obesity-related hypertension, the obese Zucker rats were treated with the insulin sensitizer[30], rosiglitazone (10 mg/kg oral, daily). This evidence concerns the gene INS and obesity disorder.